Financhill
Buy
51

HALO Quote, Financials, Valuation and Earnings

Last price:
$46.72
Seasonality move :
7.09%
Day range:
$46.88 - $48.21
52-week range:
$33.15 - $65.53
Dividend yield:
0%
P/E ratio:
15.54x
P/S ratio:
6.43x
P/B ratio:
13.19x
Volume:
4.5M
Avg. volume:
2M
1-year change:
29%
Market cap:
$6B
Revenue:
$829.3M
EPS (TTM):
$3.02

Earnings Data

Next earnings date for HALO
Feb 20
2025
Most recent earnings per share
$1.05
Beat by $0.05
(Oct 31/2024)
Consensus Estimate
$1.00
(Oct 31/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

HALO Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/20/2025 Q4 $286.1M -- -- $1.17 --
10/31/2024 Q3 $252.2M $290.1M $1.05 $1.00 $0.05
08/06/2024 Q2 $204.9M $231.4M $0.72 $0.76 -$0.04
05/07/2024 Q1 $199.6M $195.9M $0.60 $0.70 -$0.10
02/20/2024 Q4 $231.1M $230M $0.65 $0.83 -$0.18
11/06/2023 Q3 -- -- $0.61 $0.71 -$0.10
08/08/2023 Q2 -- -- $0.56 $0.64 -$0.08
05/09/2023 Q1 -- -- $0.29 $0.48 -$0.19
02/21/2023 Q4 -- -- $0.42 $0.47 -$0.05
11/08/2022 Q3 -- -- $0.44 $0.51 -$0.07
08/09/2022 Q2 -- -- $0.16 -- --
05/10/2022 Q1 -- -- $0.43 -- --
02/22/2022 Q4 -- -- $0.46 -- --
11/02/2021 Q3 -- -- $1.48 -- --
08/09/2021 Q2 -- -- $0.62 -- --
05/10/2021 Q1 -- -- $0.19 -- --
02/23/2021 Q4 -- -- $0.50 -- --
11/02/2020 Q3 -- -- $0.25 -- --
08/10/2020 Q2 -- -- $0.19 -- --
05/11/2020 Q1 -- -- -$0.04 -- --
02/24/2020 Q4 -- -- -$0.24 -- --
11/12/2019 Q3 -- -- -$0.17 -- --
08/06/2019 Q2 -- -- -$0.10 -- --
05/07/2019 Q1 -- -- $0.01 -- --
02/21/2019 Q4 -- -- -$0.01 -- --
11/06/2018 Q3 -- -- -$0.19 -- --
08/07/2018 Q2 -- -- -$0.16 -- --
05/10/2018 Q1 -- -- -$0.19 -- --
02/20/2018 Q4 -- -- $0.85 -- --
11/07/2017 Q3 -- -- $0.02 -- --
08/08/2017 Q2 -- -- -$0.23 -- --
05/09/2017 Q1 -- -- -$0.26 -- --
02/28/2017 Q4 -- -- -$0.21 -- --
11/07/2016 Q3 -- -- -$0.23 -- --
08/09/2016 Q2 -- -- -$0.21 -- --
05/09/2016 Q1 -- -- -$0.16 -- --
02/29/2016 Q4 -- -- $0.03 -- --
11/09/2015 Q3 -- -- -$0.19 -- --
08/10/2015 Q2 -- -- $0.02 -- --
05/11/2015 Q1 -- -- -$0.12 -- --
03/02/2015 Q4 -- -- -$0.04 -- --

Halozyme Therapeutics Earnings Questions

  • How Much did Halozyme Therapeutics Generate in Revenue Last Quarter?

    Halozyme Therapeutics reported $290.1M worth of top line sales in its most recent quarter.

  • Did Halozyme Therapeutics Beat Earnings Last Quarter?

    Halozyme Therapeutics announced earnings per share of $1.05 which represents a beat of analyst forecast a $1.00 per share.

  • Is Halozyme Therapeutics Profitable?

    Halozyme Therapeutics reported $240.7M that represents $1.85 per share over the last quarter.

  • What is the Analyst Consensus for Halozyme Therapeutics EPS Next Year?

    Halozyme Therapeutics's earnings are forecast to grow from $2.10 per share to $2.78 per share next year representing an increase of 96.56%.

  • When is Halozyme Therapeutics's Earnings Date?

    Halozyme Therapeutics's next earnings date is February 20, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

NVIDIA vs Broadcom Stock: Which Is Best?
NVIDIA vs Broadcom Stock: Which Is Best?

If you want to invest in an AI-leading tech company,…

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 1.43% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 7.83% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 5.8% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock